Associated Papers
ELOC-mutated Renal Cell Carcinoma: Clinicopathologic, Immunohistochemical, and Molecular Genetic Analysis of 35 Cases.
Hou J et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2026
Multigenerational VHL family characterized by pathogenic germline ELOC variant: Response to belzutifan.
Vocke CD et al.
Urologic Oncology, 2026
Comprehensive Analysis of 15 Cases of ELOC -RCC and Identification of Novel Mutation Site.
Wu Y et al.
The American Journal of Surgical Pathology, 2025
ELOC-Mutated Renal Cell Carcinoma is a Rare Indolent Tumor With Distinctive Genomic Characteristics.
Wang JJ et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2025
A case report: identifying a novel variant in ELOC(TCEB1)-mutant renal cell carcinoma.
Cheng HP et al.
Frontiers in Oncology, 2025
ELOC(TCEB1)-mutated renal cell carcinoma: a case report and clinicopathological analysis.
Zhu Y et al.
Frontiers in Oncology, 2025
Elongin C (ELOC/TCEB1)-associated von Hippel-Lindau disease.
Andreou A et al.
Human Molecular Genetics, 2022
Select a paper to view details